Pasithea Therapeutics Corp - Warrants (11/08/2026)

Pasithea Therapeutics Corp - Warrants (11/08/2026)

KTTAW - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$19.69K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Pasithea Therapeutics Corp - Warrants (11/08/2026)Pasithea Therapeutics Corp - Warrants (11/08/2026)-0.2--63%--
$13.25

Current Fair Value

473025% upside

Undervalued by 473025% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$19,687.00
Enterprise Value$-45,663,762,313.00
Earnings per Share$-2.91
Beta0.29
Outstanding Shares7,031,000

Return

Return on Equity-63.40%ROE
Return on Assets-61.11%
Return on Invested Capital-27.56%

Valuation & Multiples

P/E Ratio-0.15P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT3.32
Enterprise Value to Net Income1
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 2, 2026
EPS Estimate
$-0.16
Consensus analyst estimate
Revenue Estimate
$300,000
Consensus analyst estimate

Next Earnings Call

Expected Date
December 2, 2026
EPS Estimate
$-0.21
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %1.53%▼ 0.44%
Total Invested$3,184▼ 42.33%
Investors Holding6▲ 1.00%

About Pasithea Therapeutics Corp

2 employees

Pasithea Therapeutics - Warrants (11/08/2026) Insider Information FAQ

In the latest 13F quarter on Stockcircle, 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 1 open-market insider purchase for Pasithea Therapeutics - Warrants (11/08/2026) in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.